![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.
| 1. | Amber L. Pond, Howard W. Chambers, Cody P. Coyne, Janice E. Chambers | ||
|
|
Purification of Two Rat Hepatic Proteins with A-Esterase Activity Toward Chlorpyrifos-Oxon and Paraoxon | |
|---|---|---|---|
|
|
J. Pharmacol. Exp. Ther. Sep 01, 1998; 286: 1404-1411.
(In "ARTICLES") |
|
|
|
||
| 2. | Craig E. Crosson, Phillip W. Yates, Aruna N. Bhat, Yurii V. Mukhin, Shahid Husain | ||
|
|
Evidence for Multiple P2Y Receptors in Trabecular Meshwork Cells | |
|
|
J. Pharmacol. Exp. Ther. May 01, 2004; 309: 484-489.
(In "CELLULAR AND MOLECULAR PHARMACOLOGY") |
|
|
|
||
| 3. | Seddigheh Razani-Boroujerdi, Bruce Edwards, Mohan L. Sopori | ||
|
|
Lead Stimulates Lymphocyte Proliferation Through Enhanced T Cell-B Cell Interaction | |
|
|
J. Pharmacol. Exp. Ther. Feb 01, 1999; 288: 714-719.
(In "ARTICLES") |
|
|
|
||
| 4. | Ronald J. Tallarida | ||
|
|
Drug Synergism: Its Detection and Applications | |
|
|
J. Pharmacol. Exp. Ther. Sep 01, 2001; 298: 865-872.
(In "PERSPECTIVES IN PHARMACOLOGY") |
|
|
|
||
| 5. | Theodore A. Slotkin | ||
|
|
Fetal Nicotine or Cocaine Exposure: Which One is Worse? | |
|
|
J. Pharmacol. Exp. Ther. Jun 01, 1998; 285: 931-945.
(In "THE 1998 ASPET OTTO KRAYER AWARD LECTURE") |
|
|
|
||
| 6. | Kenji Katsuno, Yoshikazu Fujimori, Yukiko Takemura, Masahiro Hiratochi, Fumiaki Itoh, Yoshimitsu Komatsu, Hideki Fujikura, Masayuki Isaji | ||
|
|
Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level | |
|
|
J. Pharmacol. Exp. Ther. Jan 01, 2007; 320: 323-330.
(In "Endocrine and Diabetes") |
|
|
|
||
| 7. | Leo Thomas, Moh Tadayyon, Michael Mark | ||
|
|
Chronic Treatment with the Dipeptidyl Peptidase-4 Inhibitor (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356) Increases Basal Glucagon-Like Peptide-1 and Improves Glycemic Control in Diabetic Rodent Models | |
|
|
J. Pharmacol. Exp. Ther. Oct 29, 2008; doi: 10.1124/jpet.108.143966.
(In "Endocrine and Diabetes") |
|
|
|
||
| 8. | Amit Arora, Eric M. Scholar | ||
|
|
Role of Tyrosine Kinase Inhibitors in Cancer Therapy | |
|
|
J. Pharmacol. Exp. Ther. Dec 01, 2005; 315: 971-979.
(In "PERSPECTIVES IN PHARMACOLOGY") |
|
|
|
||
| 9. | Darlene C. Deecher, Chad E. Beyer, Grace Johnston, Jenifer Bray, S. Shah, M. Abou-Gharbia, Terrance H. Andree | ||
|
|
Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor | |
|
|
J. Pharmacol. Exp. Ther. Aug 01, 2006; 318: 657-665.
(In "NEUROPHARMACOLOGY") |
|
|
|
||
| 10. | Betty B Yao, Gin Hsieh, Anthony Daza, Yihong Fan, George Grayson, Tiffany Garrison, Odile El Kouhen, Bradley Hooker, Madhavi Pai, Erica Wensink, Anita Salyers, Prasant Chandran, Chang Zhu, Chengmin Zhong, Keith Ryther, Megan Gallagher, Chih-liang Chin, Ann Tovcimak, Vincent Hradil, Gerard Fox, Michael Dart, Prisca Honore, Michael Meyer | ||
|
|
Characterization of a Cannabinoid CB2 Receptor Selective Agonist, A-836339, in In Vitro Pharmacological assays and In Vivo Pain Models | |
|
|
J. Pharmacol. Exp. Ther. Oct 17, 2008; doi: 10.1124/jpet.108.145011.
(In "NEUROPHARMACOLOGY") |
|
|
|
||
| [Next 10 Articles] | |||
= from the current issue
Subscribe to Most Read feed
Last Updated: 12/09/2008 15:09:47
 |
 |
 |
|
 |
 |
 |